In the United States, nearly 9 out of 10 prescriptions filled are for generic medications, underscoring their vital role in making healthcare more affordable and accessible. By increasing market competition, generics significantly lower costs for patients and healthcare systems alike, while maintaining the same therapeutic benefits as their brand-name counterparts.
The FDA’s Office of Generic Drugs rigorously evaluates every proposed generic to ensure it is equivalent to the reference brand in terms of active ingredients, strength, dosage form, and route of administration. To gain FDA approval, generics must not only demonstrate that they perform the same way in the body, but also meet the same exacting standards for quality, safety, strength, purity, and stability.
Equally important, these medicines are manufactured in facilities held to the same strict FDA requirements as brand-name drugs. This process ensures that patients can trust generics to deliver the same effectiveness and reliability, while providing meaningful savings and broadening access to essential treatments.
Learn more on the FDA’s website https://www.fda.gov/drugs/buying-using-medicine-safely/generic-drugs